Abstract
A biofilm is defined as adherent microbial communities on biotic or abiotic surfaces surrounded by extracellular polymeric substances (EPS) matrix. Biofilm formation by bacteria is very common; however, the pathogenic filamentous fungi and yeast also form biofilms. The microbial biofilm protects microbes against harsh environments, host immune defence and antibiotics. The composition and architecture of the fungal biofilms attribute tolerance to antifungal agents and require up to 10–1000 times greater concentrations of antifungal agents than planktonic cells to eradicate biofilms. In mature biofilms, the cell metabolism is slow and demonstrates differential gene expressions compared to the counterpart planktonic cells; therefore, the common antifungal agents are ineffective on active growing cells. The mode of growth of biofilms increases the frequency of genetic exchange, which results in the origin of an antibiotic-resistant strain. Polymicrobial biofilms of bacteria and fungi is another huge challenge in which cooperation between different species has been detected. The microbial biofilm infections are persisters and resistant to antibiotic therapy. The formation of biofilm is regulated by a process called quorum sensing (cell-to-cell communication) mediated by small molecules (auto-inducers). In animals, various infectious diseases, such as otomycosis, dermatitis, stomatitis, onychomycosis, vulvovaginitis, urinary tract infection and respiratory tract infection, are caused by biofilms of Candida spp., Cryptococcus spp., Malassezia spp., Trichosporon spp., Fusarium spp., Scedosporium spp., Lomentospora prolificans and Coccidioides spp. Animal disease caused by fungi forming biofilms is a huge challenge in veterinary medicine. In this review chapter, we provide an overview of biofilm-related fungi diseases of animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adam B, Baillie GS, Douglas LJ (2002) Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 51:344–349
Aguilar-Romero F, Pérez-Romero N, Díaz-Aparicio E, Hernández-Castro R (2011) Bacterial biofilms: importance in animal diseases. In: Mendez-Vilas A (ed) In current research technology and education topics in applied microbiology and molecular biotechnology. http://microbiologia.org.mx/microbiosenlinea/capitulo04
Ajesh K, Sreejith K (2012) Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance. Mycopathologia 174:409–419
Akins RA (2005) An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43:285–318
Albertson GD, Niimi M, Cannon RD, Jenkinson HF (1996) Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 40:2835–2841
Al-Dhaheri RS, Douglas LJ (2008) Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 52:1884–1887
Al-Fattani MA, Douglas LJ (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55:999–1008
Amorena B, Gracia E, Monzóna M, Leivab J, Oteizab C, Péreza M, Alabarta J, Hernández-Yagoc J (1999) Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44:43–55
Anderson JB (2005) Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 3:547–556
Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A (2004) Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72:6023–6031
Beauvais A, Schmidt C, Guadagnini S, Roux P, Perret E, Henry C, Paris S, Mallet A, Prevost MC, Latge JP (2007) An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol 9:1588–1600
Beauvais A, Loussert C, Prevost MC, Verstrepen K, Latge JP (2009) Characterization of a biofilm-like extracellular matrix in FLO1-expressing Saccharomyces cerevisiae cells. FEMS Yeast Res 9:411–419
Bizerra FC, Nakamura CV, de Poersch C, EstivaletSvidzinski TI, Borsato Quesada RM, Goldenberg S (2008) Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res 8:442–450
Blankenship JR, Mitchell AP (2006) How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9:588–594
Bonhomme J, d’Enfert C (2013) Candida albicans biofilms: building a heterogeneous, drug-tolerant environment. Curr Opin Microbiol 16:398–403
Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P (2010) Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 65:2116–2118
Bumroongthai K, Chetanachan P, Niyomtham W, Yurayart C, Prapasarakul N (2016) Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis. MedMycol 54:544–549
Burkhart CN, Burkhart CG, Gupta AK (2002) Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol 47:629–631
Cannizzo FT, Eraso E, Ezkurra PA, Villar-Vidal M, Bollo E, Castella G (2007) Biofilm development by clinical isolates of Malassezia pachydermatis. Med Mycol 45:357–361
Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M (2007) Candida albicans drug resistance another way to cope with stress. Microbiology 153:3211–3217
Carlson E (1982) Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality. Infect Immun 38:921–924
Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385–5394
Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS (2001) Cryptococcus laurentii fungemia in a premature neonate. J Clin Microbiol 39:1608–1611
Costa-Orlandi CB, Magalhães GM, Oliveira MB, Taylor EL, Marques CR, de Resende-Stoianoff MA (2012) Prevalence of dermatomycosis in a Brazilian tertiary care hospital. Mycopathologia 174:489–497
Costa-Orlandi CB, Sardi JCO, Pitangui NS, de Oliveira HC, Scorzoni L, Galeane MC, Mendes-Giannini MJS (2017) Fungal biofilms and polymicrobial diseases. J Fungi 3:22. https://doi.org/10.3390/jof3020022
Costerton JW, Cheng KJ, Gersey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41:435–464
Cushion MT, Collins MS, Linke MJ (2009) Biofilm formation by Pneumocystis spp. Eukaryot Cell 8:197–206
D’Antonio D, Parruti G, Pontieri E, Di Bonaventura G, Manzoli L, Sferra R (2004) Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. Eur J Clin Microbiol Infect Dis 23:787–789
Davis LE, Cook G, Costerton JW (2002) Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg Infect Dis 8:376–379
De Beer D, Stoodley P, Lewandowski Z (1994) Liquid flow in heterogeneous biofilms. Biotechnol Bioeng 44:636–641
De Carvalho FG, Silva DS, Hebling J, Spolidorio LC, Spolidorio DMP (2006) Presence of mutans streptococci and Candida spp. in dental plaque/dentine of carious teeth and early childhood caries. Arch Oral Biol 51:1024–1028
Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D’Antonio D, Piccolomini R (2006) Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 50:3269–3276
Falsetta ML, Klein MI, Colonne PM, Scott-Anne K, Gregoire S, Pai C (2014) Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes the virulence of plaque-biofilms in vivo. Infect Immun 82:1968–1981
Finkel JS, Mitchell AP (2011) Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 9:109–118
Gonzalez-Ramirez AI, Ramirez-Granillo A, Medina-Canales MG, Rodriguez-Tovar AV, Martinez-Rivera MA (2016) Analysis and description of the stages of Aspergillus fumigatus biofilm formation using scanning electron microscopy. BMC Microbiol 16:243
Gregoire S, Xiao J, Silva BB, Gonzalez I, Agidi PS, Klein MI et al (2011) Role of glucosyltransferase B in interactions of Candida albicans with Streptococcus mutans and with an experimental pellicle on hydroxyapatite surfaces. Appl Environ Microbiol 77:6357–6367
Harding MW, Marques LL, Howard RJ, Olson ME (2009) Can filamentous fungi form biofilms? Trends Microbiol 17:475–480
Harriott MM, Noverr MC (2009) Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother September 53:3914–3922
Henriques M, Azeredo J, Oliveira R (2006) Candida albicans and Candida dubliniensis: comparison of biofilm formation in terms of biomass and activity. Br J Biomed Sci 63:5–11
Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, Shoemaker R et al (2001) Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67:2982–2992
Imamura Y, Chandra J, Mukherjee PK, Lattif AA, Szczotka-Flynn LB, Pearlman E, Lass JH, O’Donnell K, Ghannoum MA (2008) Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother 52:171–182
Ingram CW, Haywood HB 3rd, Morris VM, Allen RL, Perfect JR (1993) Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. Infect Control Hosp Epidemiol 14:719–722
Iturrieta-Gonzalez IA, Padovan AC, Bizerra FC, Hahn RC, Colombo AL (2014) Multiple species of trichosporon produce biofilms highly resistant to triazoles and amphotericin B. PLoS One 9:e109553
Jadhav VJ, Pal M (2013) Human and domestic animal infections caused by Candida albicans. J Mycopathol Res 551:243–249
Jefferson KK (2004) What drives bacteria to produce a biofilm? FEMS Microbiol Lett 236:163–173
Kaur S, Singh S (2014) Biofilm formation by Aspergillus fumigatus. Med Mycol 52:2–9
Khawcharoenporn T, Apisarnthanarak A, Kiratisin P, Mundy LM, Bailey TC (2006) Evaluation of Cryptococcus laurentii meningitis in a patient with HIV infection: a case report and review of the literature. Hawaii Med J 65:260–263
Khawcharoenporn T, Apisarnthanarak A, Mundy LM (2007) Non-neoformans cryptococcal infections: a systematic review. Infection 35:51–58
Khot PD, Suci PA, Miller RL, Nelson RD, Tyler BJ (2006) A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Antimicrob Agents Chemother 50:3708–3716
Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN (2007) Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 59:401–406
Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17:255–267
Kumamoto CA (2005) A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci U S A 102:5576–5581
LaFleur MD, Kumamoto CA, Lewis K (2006) Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 50:3839–3846
Lawrence JR, Korber DR, Hoyle BD, Costerton JW, Caldwell DE (1991) Optical sectioning of microbial biofilms. J Bacteriol 173:6558–6567
Lewis K (2010) Persister cells. Annu Rev Micro 64:357–372
Lopez-Ribot JL, McAtee RK, Perea S, Kirkpatrick WR, Rinaldi MG, Patterson TF (1999) Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 43:1621–1630
Malik R, Alderton B, Finlaison D et al (2002) Cryptococcosis in ferrets: a diverse spectrum of clinical disease. Aust Vet J 80:749–755
Marcos-Zambrano LJ, Gomez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J (2016) Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species. Antimicrob Agents Chemother 60:3579–3586
Marsh PD (1999) Microbiologic aspects of dental plaque and dental caries. Dent Clin N Am 43:599–614
Martinez LR, Casadevall A (2006) Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 50:1021–1033
Martinez LR, Mihu MR, Han G, Frases S, Cordero RJ, Casadevall A, Friedman AJ, Friedman JM, Nosanchuk JD (2010) The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials 31:669–679
Mello TP, Aor A, Goncalves DS, Seabra SH, Branquinha MH, Santos AL (2016) Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans. Biofouling 32:737–749
Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annurev Micro 55:165–199
Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71:4333–4340
Mukherjee PK, Chandra J, Yu C, Sun Y, Pearlman E, Ghannoum MA (2012) Characterization of Fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis. Investig Ophthalmol Vis Sci 53:4450–4457
Müller FM, Seidler M, Beauvais A (2011) Aspergillus fumigatus biofilms in the clinical setting. Med Mycol 49:S96–S100
Nett JE, Lepak AJ, Marchillo K, Andes DR (2009) Time course global gene expression analysis of an in vivo Candida biofilm. J Infect Dis 200:307–313
Niimi M, Firth NA, Cannon RD (2010) Antifungal drug resistance of oral fungi. Odontology 98:15–25
Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A et al (2009) Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 7:e1000133
Peiqian L, Xiaoming P, Huifang S, Jingxin Z, Ning H, Birun L (2013) Biofilm formation by Fusarium oxysporum f. sp. cucumerinum and susceptibility to environmental stress. FEMS Microbiol Lett 350:138–145
Pereira-Cenci T, Deng DM, Kraneveld EA, Manders EMM, Del Bel Cury AA, ten Cate JM et al (2008) The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces. Arch Oral Biol 53:755–764
Pettit RK, Repp KK, Hazen KC (2010) Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents. Med Mycol 48:421–426
Piddock LJ (2006) Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4:629–636
Pires RH, Santo s JM, Zaia JE, Martins CH, Mendes-Giannini MJ (2011) Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals. Memórias Inst Oswaldo Cruz 106:646–654
Pitangui NS, Sardi JC, Silva JF, Benaducci T, Moraes da Silva RA, Rodriguez-Arellanes G, Taylor ML, Mendes-Giannini MJ, Fusco-Almeida AM (2012) Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface. Biofouling 28:711–718
Rajendran R, Williams C, Lappin DF, Millington O, Martins M, Ramage G (2013) Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot Cell 12:420–429
Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL (2005) Candida biofilms: an update. Eukaryot Cell 4:633–638
Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35:340–355
Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C (2011) Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol Lett 324:89–97
Ramage G, Milligan S, Lappin DF, Sherry L, Sweeney P, Williams C et al (2012) Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients. Front Microbiol 3:220
Sanglard D, Ischer F, Monod M, Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143:405–416
Sardi Jde C, Pitangui Nde S, Voltan AR, Braz JD, Machado MP, Fusco Almeida AM, Mendes Giannini MJ (2015) In vitro Paracoccidioides brasiliensis biofilm and gene expression of adhesins and hydrolytic enzymes. Virulence 6:642–651
Scorzoni L, de PaulaeSilva ACA, Marcos CM, Assato PA, de Melo WCMA, de Oliveira HC, Costa-Orlandi CB, Mendes-Giannini MJS, Fusco-Almeida AM (2017) Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol 8:36
Shankar EM, Kumarasamy N, Bella D et al (2006) Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J 13:275–278
Shapiro RS, Robbins N, Cowen LE (2011) Regulatory circuitry governing fungal development, drug resistance and disease. Microbiol Mol Biol Rev 75:213–267
Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J (2009) Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol 47:681–689
Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J (2011) Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 36:288–305
Singh R, Shivaprakash MR, Chakrabarti A (2011) Biofilm formation by zygomycetes: quantification, structure and matrix composition. Microbiology 157:2611–2618
Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5:418–430
Sykes JE, Sturges BK, Cannon MS et al (2010) Clinical signs, imaging features, neuropathology, and outcome in cats and dogs with central nervous system cryptococcosis from California. J Vet Intern Med 24:1427–1438
Thein Z, Seneviratne C, Samaranayake Y, Samaranayake L (2009) Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses 52:467–475
Tre-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ (2008) In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Int J Antimicrob Agents 31:329–336
Tsui C, Kong EF, Jabra-Rizk MA (2016) Pathogenesis of Candida albicans biofilm. Pathog Dis 74:ftw018
Walsh TJ, Schlegel R, Moody MM, Costerton JW, Salcman M (1986) Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 18:373–375
Weitzman I, Summerbell RC (1995) The dermatophytes. Clin Microbiol Rev 8:240–259
Williams C, Rajendran R, Ramage G (2016) Aspergillus biofilms in human disease. Adv Exp Med Biol 931:1–11
Wosten HA (2001) Hydrophobins: multipurpose proteins. Annu Rev Microbiol 55:625–646
Xiao J, Moon Y, Li L, Rustchenko E, Wakabayashi H, Zhao X et al (2016) Candida albicans carriage in children with severe early childhood caries (S-ECC) and maternal relatedness. PLoS One 11:e0164242
Xie Z, Thompson A, Sobue T, Kashleva H, Xu H, Vasilakos J et al (2012) Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J Infect Dis 206:1936–1945
Xu H, Jenkinson HF, Dongari-Bagtzoglou A (2014) Innocent until proven guilty: mechanisms and roles of Streptococcus–Candida interactions in oral health and disease. Mol Oral Microbiol 29:99–116
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yadav, M.K., Malvi, Y. (2019). Animal Infections: The Role of Fungal Biofilms. In: Gupta, A., Singh, N. (eds) Recent Developments in Fungal Diseases of Laboratory Animals. Fungal Biology. Springer, Cham. https://doi.org/10.1007/978-3-030-18586-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-18586-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18585-5
Online ISBN: 978-3-030-18586-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)